Home / Current Issue / Paper 1702290
The Corona(COVID-19) (SARS-CoV-2) Cure using Blood Transfusion and Machine Learning
Subject area: Science,Engineering and Technology · Area of research: Science and Engineering
Abstract
(SARS-CoV-2; previously provisionally been named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the tip of 2019 had caused an outsized global outbreak and it is a significant public health issue. As of 6th May 2020, data from the World Health Organization (WHO) have shown that quite 3.4 Million cases out of which 1.27 M somehow manages to recover whereas 265k is unfortunately dead which is identified in 28 countries/regions. On 30th January 2020, WHO declared COVID-19 the sixth public health emergency of international concern. It's spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to possess a mean period of 6.4 days, and a basic reproduction number of two. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the foremost common symptom, followed by a cough. Bilateral lung involvement with ground-glass opacity was the foremost common finding from CAT images of the chest. The one case of SARS-CoV-2 pneumonia within the USA is responding well to redeliver, which is now undergoing a test in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the first intervention getting used. However, public health authorities should keep monitoring true closely, because the more we are visiting to study this novel virus, and its associated outbreak. The purpose of this study is to put forth a theory about how blood transfusion from a corona recovered patient to a normal person could help the normal person to be immune to the virus. This treatment can also be termed as passive immunization as of PMC paper on blood transfusion in paragraph 1.
How to cite this paper
@article{1702290,
author = {Asim Sayyed},
title = {The Corona(COVID-19) (SARS-CoV-2) Cure using Blood Transfusion and Machine Learning},
journal = {Iconic Research And Engineering Journals},
year = {2020},
volume = {3},
number = {11},
pages = {64-72},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1702290.pdf},
abstract = {(SARS-CoV-2; previously provisionally been named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the tip of 2019 had caused an outsized global outbreak and it is a significant public health issue. As of 6th May 2020, data from the World Health Organization (WHO) have shown that quite 3.4 Million cases out of which 1.27 M somehow manages to recover whereas 265k is unfortunately dead which is identified in 28 countries/regions. On 30th January 2020, WHO declared COVID-19 the sixth public health emergency of international concern. It's spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to possess a mean period of 6.4 days, and a basic reproduction number of two. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the foremost common symptom, followed by a cough. Bilateral lung involvement with ground-glass opacity was the foremost common finding from CAT images of the chest. The one case of SARS-CoV-2 pneumonia within the USA is responding well to redeliver, which is now undergoing a test in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the first intervention getting used. However, public health authorities should keep monitoring true closely, because the more we are visiting to study this novel virus, and its associated outbreak. The purpose of this study is to put forth a theory about how blood transfusion from a corona recovered patient to a normal person could help the normal person to be immune to the virus. This treatment can also be termed as passive immunization as of PMC paper on blood transfusion in paragraph 1.},
month = {May},
}